Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn Servaes

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 9, 2025
Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
JAMA Neurology|December 12, 2022
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Marie Vermeiren, Stijn Servaes, et al.
Nature Neuroscience|November 6, 2025
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Brain : a Journal of Neurology|January 29, 2025
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrumJaime Fernández Arias, Wagner S Brum, Gemma Salvadó, et al.
The Journal of Prevention of Alzheimer'S Disease|June 5, 2025
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseaseSarah Abbas, Pamela C L Ferreira, Bruna Bellaver, et al.
Molecular Psychiatry|August 10, 2022
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Pâmela C L Ferreira, Bruna Bellaver, et al.
Nature Medicine|May 29, 2023
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
Nature Aging|September 25, 2023
APOEε4 potentiates amyloid β effects on longitudinal tau pathologyJoão Pedro Ferrari-Souza, Bruna Bellaver, Pâmela C L Ferreira, et al.
JAMA Network Open|November 27, 2023
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseCristiano Schaffer Aguzzoli, Pâmela C L Ferreira, Guilherme Povala, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 9, 2025
Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
JAMA Neurology|December 12, 2022
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Marie Vermeiren, Stijn Servaes, et al.
Nature Neuroscience|November 6, 2025
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Brain : a Journal of Neurology|January 29, 2025
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrumJaime Fernández Arias, Wagner S Brum, Gemma Salvadó, et al.
The Journal of Prevention of Alzheimer'S Disease|June 5, 2025
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseaseSarah Abbas, Pamela C L Ferreira, Bruna Bellaver, et al.
Molecular Psychiatry|August 10, 2022
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Pâmela C L Ferreira, Bruna Bellaver, et al.
Nature Medicine|May 29, 2023
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
Nature Aging|September 25, 2023
APOEε4 potentiates amyloid β effects on longitudinal tau pathologyJoão Pedro Ferrari-Souza, Bruna Bellaver, Pâmela C L Ferreira, et al.
JAMA Network Open|November 27, 2023
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseCristiano Schaffer Aguzzoli, Pâmela C L Ferreira, Guilherme Povala, et al.
Pageof 10